These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3501162)

  • 1. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
    Pfisterer M; Jockers G; Burkart F; Schmitt HE; Wolff G; Skarvan K; Stulz P; Hasse J; Grädel E
    Schweiz Med Wochenschr; 1987 Oct; 117(43):1688-92. PubMed ID: 3501162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.
    Pantely GA; Goodnight SH; Rahimtoola SH; Harlan BJ; DeMots H; Calvin L; Rösch J
    N Engl J Med; 1979 Nov; 301(18):962-6. PubMed ID: 386118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
    Loeliger EA
    Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
    [No Abstract]   [Full Text] [Related]  

  • 4. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
    Pfisterer M; Jockers G; Regenass S; Schmitt HE; Grädel E; Burkart F
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1518-20. PubMed ID: 2692145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
    Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
    N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 10. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Visser J
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts.
    Kohler TR; Kaufman JL; Kacoyanis G; Clowes A; Donaldson MC; Kelly E; Skillman J; Couch NP; Whittemore AD; Mannick JA
    Surgery; 1984 Sep; 96(3):462-6. PubMed ID: 6474351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and anticoagulant therapy after coronary bypass.
    Phillips SJ; Kongtahworn C; Zeff RH; Beshany SE
    N Engl J Med; 1980 Apr; 302(15):866. PubMed ID: 6965762
    [No Abstract]   [Full Text] [Related]  

  • 13. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Dec; 137(51):2669. PubMed ID: 8278004
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication.
    Pirk J; Vojácek J; Kovác J
    Cor Vasa; 1986; 28(3):177-80. PubMed ID: 3527555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
    Shennib H; Endo M; Benhameid O
    Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
    Pfisterer M; Jockers G; Meier B; Schmitt HE; Stulz P; Hasse J; Grädel E; Burkart F
    Helv Chir Acta; 1987 Feb; 53(4):497-500. PubMed ID: 3494713
    [No Abstract]   [Full Text] [Related]  

  • 19. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Houben JJ; Nicolai G
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173
    [No Abstract]   [Full Text] [Related]  

  • 20. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
    Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
    Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.